학술논문
1023P - Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients
Document Type
Abstract
Author
Berton-Rigaud, D.; Floquet, A.; Mollon-Grange, D.; Dechartres, A.; Lescaut, W.; Kaminsky-Forrett, M.-C.; Tredan, O.; Largillier, R.; Savoye, A.M.; Alexandre, J.; Delbaldo, C.; Malaurie, E.; Barletta, H.; Bosacki, C.; Tixidre, C Garnier; Follana, P.; Laharie-Mineur, H.; Levaché, C.-B.; Pujade-Lauraine, E.; Selle, F.
Source
In Annals of Oncology October 2019 30 Supplement 5:v418-v418
Subject
Language
ISSN
0923-7534